Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT00008177||Active, not recruiting||Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes||
||Other / NIH||
||79||All||50 Years and older (Adult, Senior)||NCT00008177||1432.00
|July 27, 1999||March 21, 2009||December 12, 2003||November 8, 2017||